Jan 2026· Engineering Biology· Vol 10· 0 citations· 85 references
Medicine
TL;DR
This Perspective examines the trajectory of Spain's synthetic biology community, highlighting foundational contributions, current strengths and emerging opportunities, and the need to balance engineering ambition with biological complexity, innovation with deployability and control with emergence.
Abstract
ABSTRACT Spain has undergone a rapid and profound transformation in synthetic biology and bioengineering over the past two decades. What began as a research landscape rooted in classical molecular biology has evolved into a dynamic, multi‐institutional ecosystem that integrates bottom‐up synthetic cell engineering, top‐down reprogramming of living systems and computational and AI‐driven design. This Perspective examines the trajectory of Spain's synthetic biology community, highlighting foundational contributions, current strengths and emerging opportunities. Special emphasis is placed on Spain's role in European synthetic cell initiatives, its participation in global biofoundry networks, the establishment of one of the most successful standardisation initiatives—the SEVA platform—and the development of advanced training programs, including the MISB Master's and the SYNBIO‐CSIC COFUND doctoral network. Together, these elements position Spain as an active European actor in engineering biology, with growing influence in the matter‐to‐life nexus, biomanufacturing and sustainable biotechnology. Finally, the manuscript discusses key technical, regulatory, conceptual and translational challenges facing the field, particularly the need to balance engineering ambition with biological complexity, innovation with deployability and control with emergence. Only by addressing these tensions can it move from promise to widespread impact.
The 8th edition of the Annual Canadian Synthetic Biology Symposium (SynBio 8.0) was hosted at the University of Waterloo from June 15 to 17th. It brought together around 140 attendees from across Canada, as well as international participants. Organized by the Waterloo Centre for Microbial Research (WCMR) alongside SynB...
Jérémy Gagnon, Caitlin Oh, Aracely Maribel Diaz-Garza· Canadian Journal of Microbio...· 0 citations
This review systematically summarizes progress in foundational tools and key supporting technologies of synthetic biology, highlights innovative strategies and clinical value in biosensors, cell therapy, living therapeutics, and smart biomaterials, and provides an in-depth comparison of different chassis cells, deliver...
Chen-Xuan Li, Zi-Xuan Liu, Yu-Fang Lin et al.· Molecular Biomedicine· 0 citations
The convergence of synthetic biology and artificial intelligence is widening the gap between technological advancement and existing regulatory frameworks - a phenomenon known as regulatory lag. As global competition intensifies to capture a synthetic biology market projected to reach approximately $70 billion by 2030,...
Hyeonsu Kim, Yeji Kwon, Heoung-yeol Kim et al.· Journal of Microbiology· 0 citations
The transition toward a global circular bioeconomy needs a multi-dimensional approach that integrates technical knowledge and innovation with effective science communication and robust policymaking. This manuscript examines the interconnected journey of biotechnological solutions for environmental sustainability, movin...
S. Bertacchi· Biotechnology for the Enviro...· 0 citations
Precision microalgae is proposed as a conceptual framework that integrates reactor engineering and cell physiology with three operational pillars: real-time monitoring, predictive modeling, and adaptive control to connect currently fragmented technological and biological advances within a common framework for managing...
Darissa Alves Dutra, R. L. S. Machado, M. Deprá et al.· Bioengineering· 0 citations
This Review evaluates the technological and translational trajectories that have defined the iPSC era and analyzes the operational barriers to therapeutic development, envisioning a paradigm shift in which iPSC-derived interventions transition from bespoke experimental models toward standardized, engineered biological...
Jaecheol Lee, Todd J. Herron, L. Studer et al.· Nature Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.